Dear Christoph, dear all

I am also ready to give feedback on draft reports. But I would like that we are doing it in a better, more organized way than with earlier reports.

I think a main problem in the past was, that we have often received 3, 4, 5 or even more versions of the report and you have always asked for feedback – If this happens everybody will stop to give feedback after a while – as everybody has a lot of work and is not able to comment many times the same report.

Therefore my wish would be to comment the draft report twice. Once when it is ca. 90% finalized and also bigger, structural changes are still possible (ca. 2 weeks before publication ?) and once when it is finalized, and we could just changes sentences and words.

I agree with with the comments made by Katherine – maybe with one exception. When we have one or two animals in our cases – this sometimes helps to to build awareness in other circles/media – and this could helpful for our fight. So I would rather keep them.

Best

François

Von: Npos_2018 npos_2018-bounces@testbiotech.de Im Auftrag von ARCHE NOAH Katherine Dolan Gesendet: Donnerstag, 5. März 2020 17:29 An: Christoph Then info@no-patents-on-seeds.org; npos_2018@testbiotech.de Betreff: Re: [Npos_2018] first round of examples explained for the report

Dear Christoph,

I am happy to work on the report.

My comments:

It may be part of your introduction, but I think it is important to have a section on the democratic deficit, highlighting that the decision of elected governments - at both the EU level and in the Admin Council - is being called into question by technocrats whose work is financed by big business.

I wonder if, to save time and keep the report length down, we should leave out the chapter on livestock? You could perhaps just mention in the introduction that it is also affected, and briefly mention a couple of the most scandalous cases.

I do not think we should go into detail in this report on political strategies and legal solutions in this report, but rather stay very high level just stating our overall aims. We then go into more detail after the announcement of the EPO, and after our discussions with the Contracting States. I’m think this is what we agreed last week.

It would be good to include some headline figures (like from your presentation last week) that we can use in the media work, and possibly also some of Ruth´s great graphs.

It would be helpful for our work at the national level if we could include, for each patent case, the information if the patent has also already been registered at the EP (and if so for which countries). It is frustrating, but my experience has been that the Austrian media only wants to report about cases that directly affect Austria. (I got some negative feedback after they found out two of the Carlsberg patents don´t apply here.)

Perhaps for each patent case we could have two check boxes (or a summary table at the end) with the criteria – to make it crystal clear:

"If the decision of the Administrative Council is confirmed, this patent can be granted?"

"If the decision of the Administrative Council is repealed, this patent can be granted?"

Can we plan a time for a call on the report after you have circulated the draft to discuss it and the plan for the press release / media work?

Thanks

Katherine

-----Ursprüngliche Nachricht----- Von: Npos_2018 [mailto:npos_2018-bounces@testbiotech.de] Im Auftrag von Christoph Then Gesendet: Dienstag, 3. März 2020 18:06 An: npos_2018@testbiotech.de mailto:npos_2018@testbiotech.de Betreff: [Npos_2018] first round of examples explained for the report

Dear all

in our meeting we discussed that cases of random mutagenesis might become most important in the upcoming weeks. So I started to work on the examples for the report.

please see attached - just for reading and general comments - my rough first draft.

you also can see a preliminary table of the overall content /structure of the report and list of examples I selected to work with in the next days (not concerning random mutagenesis).

I guess the report it will become a minimum of ten pages ..

I would be interested to know who besides Ruth, Johanna and Anne Charlotte wants to get involved in discussing the further drafts? Since we have some time pressure, we should try to work straight forward.

happy to get your general comments

cheers

Christoph

dear Katherine

thanks for your first comments!

please be aware that the draft as sent is just an overview. The Issues you mention can be introduced at later stage. At the moment I would not recommend to leave aside animals. But this might be re-discussed at later stage.

The question whether patent applications will be granted if Rule 28 (2) is confirmed, is important. The first examples I sent all would be patentable as being based on mutations breeding. There will be other examples.

Regarding Austria, we might introduce some information on the  UPC which would mean direct validation in Austria.

Regarding the media strategy another mail will follow.

cheers

Christoph

Am 05.03.20 um 17:28 schrieb ARCHE NOAH Katherine Dolan:

Dear Christoph,   I am happy to work on the report.   My comments:   It may be part of your introduction, but I think it is important to have a section on the democratic deficit, highlighting that the decision of elected governments - at both the EU level and in the Admin Council - is being called into question by technocrats whose work is financed by big business.   I wonder if, to save time and keep the report length down, we should leave out the chapter on livestock? You could perhaps just mention in the introduction that it is also affected, and briefly mention a couple of the most scandalous cases.   I do not think we should go into detail in this report on political strategies and legal solutions in this report, but rather stay very high level just stating our overall aims. We then go into more detail _after_ the announcement of the EPO, and after our discussions with the Contracting States. I’m think this is what we agreed last week.   It would be good to include some headline figures (like from your presentation last week) that we can use in the media work, and possibly also some of Ruth´s great graphs.   It would be helpful for our work at the national level if we could include, for each patent case, the information if the patent has also already been registered at the EP (and if so for which countries). It is frustrating, but my experience has been that the Austrian media only wants to report about cases that directly affect Austria. (I got some negative feedback after they found out two of the Carlsberg patents don´t apply here.)   Perhaps for each patent case we could have two check boxes (or a summary table at the end) with the criteria – to make it crystal clear: "If the decision of the Administrative Council is confirmed, this patent can be granted?" "If the decision of the Administrative Council is repealed, this patent can be granted?"   Can we plan a time for a call on the report after you have circulated the draft to discuss it and the plan for the press release / media work?   Thanks Katherine   -----Ursprüngliche Nachricht----- Von: Npos_2018 [mailto:npos_2018-bounces@testbiotech.de] Im Auftrag von Christoph Then Gesendet: Dienstag, 3. März 2020 18:06 An: npos_2018@testbiotech.de Betreff: [Npos_2018] first round of examples explained for the report   Dear all     in our meeting we discussed that cases of random mutagenesis might become most important in the upcoming weeks. So I started to work on the examples for the report.   please see attached - just for reading and general comments - my rough first draft.   you also can see a preliminary table of the overall content /structure of the report and list of examples I selected to work with in the next days (not concerning random mutagenesis).   I guess the report it will become a minimum of ten pages ..     I would be interested to know who besides Ruth, Johanna and Anne Charlotte wants to get involved in discussing the further drafts? Since we have some time pressure, we should try to work straight forward.   happy to get your general comments   cheers   Christoph

---

Npos_2018 mailing list Npos_2018@testbiotech.de https://lists.testbiotech.de/cgi-bin/mailman/listinfo/npos_2018